Jiangsu Apon Medical Technology Co., Ltd. (SHE:300753)
China · Delayed Price · Currency is CNY 20.37
+0.36 (1.80%)
Sep 14, 2026, 3:04 PM CST
SHE:300753 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 331.61 | 342.02 | 403.8 | 422.17 | 323.81 | 461.21 |
Revenue Growth | -13.53% | -15.30% | -4.35% | 30.38% | -29.79% | 4.09% |
Gross Profit Gross Profit Growth | 228.37 | 231.62 | 276.06 | 276.46 | 159.99 | 294.88 |
Operating Income Operating Income Growth | -16.06 | -29.53 | 18 | 11.66 | -80.72 | 48.12 |
Net Income Net Income Growth | -14.53 | -24.02 | 10.8 | 8.28 | -75.98 | 54.06 |
Earnings Per Share EPS Growth | -0.12 | -0.19 | 0.09 | 0.07 | -0.60 | 0.43 |
EPS Growth | - | - | 30.44% | - | - | -44.24% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pain Management Products Pain Management Products Growth | 205.57 | 248.43 | 220.98 | 117.39 | 252.25 |
Nasal and Upper Airway Products Nasal and Upper Airway Products Growth | 112.7 | 123.38 | 183.1 | 126.1 | 133.9 |
Other Other Growth | 21.09 | 30.5 | 16.71 | 79.88 | 63.86 |
Unallocated Other Operations Unallocated Other Operations Growth | 2.65 | 1.5 | 1.38 | 0.43 | - |
Total Total Growth | 342.02 | 403.8 | 422.17 | 323.81 | 460.72 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 83.95 | 164.6 | 202.64 | 201.9 | 249.25 | 274.66 |
Total Debt Total Debt Growth | 84.97 | 120.8 | 81.96 | 75.42 | 68.37 | 39.86 |
Net Cash (Debt) Net Cash Growth | -1.02 | 43.81 | 120.67 | 126.48 | 180.88 | 234.81 |
Net Cash Growth | - | -63.70% | -4.59% | -30.08% | -22.97% | -39.57% |
Net Cash Per Share Net Cash Per Share Growth | -0.01 | 0.35 | 0.96 | 1.00 | 1.44 | 1.86 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 37.77 | 2.33 | 15.68 | -23.34 | -24.59 | 18.29 |
Capital Expenditures CapEx Growth | -8.08 | -8.43 | -10.23 | -30.73 | -24.17 | -39.6 |
Free Cash Flow Free Cash Flow Growth | 29.69 | -6.1 | 5.45 | -54.07 | -48.76 | -21.31 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 68.87% | 67.72% | 68.37% | 65.49% | 49.41% | 63.94% |
Operating Margin | -4.84% | -8.63% | 4.46% | 2.76% | -24.93% | 10.43% |
Pretax Margin | -4.74% | -7.63% | 5.24% | 3.27% | -28.01% | 11.99% |
Profit Margin | -4.38% | -7.02% | 2.67% | 1.96% | -23.46% | 11.72% |
FCF Margin | 8.95% | -1.78% | 1.35% | -12.81% | -15.06% | -4.62% |
| Fiscal Year | FY 2024 | FY 2023 |
|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.065 | 0.065 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.37% | 0.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 205.75 | 261.47 | - | 47.31 |
Forward PE | - | 29.75 | 29.75 | 29.75 | 29.75 | 29.75 |
P/FCF Ratio | 86.47 | - | 407.60 | - | - | - |
PS Ratio | 7.74 | 10.23 | 5.50 | 5.13 | 7.03 | 5.55 |